Gene: LDHC
Official Full Name: lactate dehydrogenase Cprovided by HGNC
Gene Summary: Lactate dehydrogenase C catalyzes the conversion of L-lactate and NAD to pyruvate and NADH in the final step of anaerobic glycolysis. LDHC is testis-specific and belongs to the lactate dehydrogenase family. Two transcript variants have been detected which differ in the 5' untranslated region. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
GP00496 | LDHC gRNA1-gRNA2 KO plasmid | LDHC | $850 | |||
KO08226 | LDHC Knockout cell line (HEK293) | Human | LDHC | 1:3~1:6 | Negative | Online Inquiry |
LDHC Gene Knockout Cell Lines are genetically engineered cell models designed to facilitate the study of Lactate Dehydrogenase C (LDHC) function and its implications in various physiological and pathological processes. By utilizing CRISPR-Cas9 technology, these cell lines have been specifically modified to lack functional LDHC, allowing researchers to investigate the enzyme's role in metabolic pathways, cellular response to hypoxia, and tumorigenesis. The knockout mechanism effectively leads to the disruption of LDHC protein expression, providing a powerful tool for studying metabolic shifts and lactate production in cancer cells or other tissues where LDHC may be pivotal.
The importance of LDHC Gene Knockout Cell Lines extends far beyond basic research. In clinical settings, understanding the metabolic dysregulation associated with LDHC offers insights into cancer progression, providing potential pathways for therapeutic intervention. The ability to examine the differentiated behaviors of these knockout cells compared to their wild-type counterparts can illuminate critical aspects of tumor biology, including cell proliferation, migration, and resistance to apoptosis.
Compared to traditional cell models, our LDHC Gene Knockout Cell Lines present unique advantages such as precise gene editing, resulting in a reproducible phenotype. Alternative methods, like siRNA knockdown, often yield transient effects that can complicate data interpretation. In contrast, our knockout lines provide stable, long-term studies against which researchers can validate their findings, leading to more impactful research outputs.
For researchers and clinicians focused on cancer biology, metabolism, or metabolic disorders, LDHC Gene Knockout Cell Lines represent an invaluable asset that enhances experimental robustness and enables innovative exploration of cellular behavior. With our company’s steadfast experience in creating high-quality biological products, we ensure that these cell lines are produced under stringent quality controls, providing researchers with the reliability they need to push the boundaries of their investigations.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.